The results on DSS were in line with the OS analysis, showing similar effect of CD86 expression in the five cancer types: CESC (HR = 0.611, 95%CI [0.436, 0.856], Cox P = 0.004), LGG (HR = 1.555, 95%CI [1.261, 1.917], Cox P < 0.001), SKCM (HR = 0.696, 95%CI [0.604, 0.803], Cox P < 0.001), THYM (HR = 3.603, 95%CI [1.082, 11.993], Cox P = 0.037) and UVM (HR = 2.112, 95%CI [1.160, 3.845], Cox P = 0.014) (Figure 2B). This evidence concerns the gene CD86 and cancer.